Previous 10 | Next 10 |
Arcturus Therapeutics Holdings ( ARCT +6.1% ) perks up, albeit on below-average volume, on the heels of new preclinical data supporting its COVID-10 vaccine program LUNAR-COV19. More news on: Arcturus Therapeutics Holdings Inc., Healthcare stocks news, Stocks on the move, Read more...
New data provides evidence of adaptive cellular (CD8+ cells) and balanced (Th1/Th2) immune responses STARR™ mRNA elicits anti-spike protein antibodies (IgG), higher than conventional mRNA at all doses SAN DIEGO, May 08, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings...
Arcturus Therapeutics (NASDAQ: ARCT ): Q1 GAAP EPS of -$0.67 misses by $0.08 . More news on: Arcturus Therapeutics Holdings Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Important progress advancing COVID-19 STARR™ mRNA vaccine candidate (LUNAR-COV19); New preclinical data demonstrate robust immunogenicity with a single, low dose Company remains on track to begin clinical trial for COVID-19 vaccine this summer Successfully raised net...
Arcturus Therapeutics Holdings (NASDAQ: ARCT), a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, has closed an underwritten public offering of 4,735,297 shares of its common stock...
SAN DIEGO, May 04, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rar...
SAN DIEGO and SOMERSET, N.J., May 04, 2020 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (“Arcturus”, “the Company”, Nasdaq: ARCT), a leading clinical-stage messenger RNA (mRNA) medicines and vaccines company, and Catalent, Inc. (NYSE: CTLT), the leadin...
Broadwind Energy (NASDAQ: BWEN ) +60% . on $19M order . More news on: Broadwind Energy, Inc., TrovaGene, Inc., SmileDirectClub, Inc., Stocks on the move, , Read more ...
Gainers: Yield10 Bioscience (NASDAQ: YTEN ) +68% . More news on: Yield10 Bioscience, Inc., Aytu BioScience, Inc., Avadel Pharmaceuticals plc, Stocks on the move, , Read more ...
Axsome Therapeutics (NASDAQ: AXSM ) +44% as Avadel Pharmaceuticals gains 34% on positive data on lead drug. More news on: Axsome Therapeutics, Inc., Avadel Pharmaceuticals plc, Yield10 Bioscience, Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Arcturus Therapeutics Ltd. Company Name:
ARCT Stock Symbol:
NASDAQ Market:
Arcturus Therapeutics Ltd. Website:
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and medicines to treat unmet medical needs within liver and respiratory rare diseases, toda...
2024-07-02 10:15:03 ET Piper Sandler analyst issues OVERWEIGHT recommendation for ARCT on July 2, 2024 08:19AM ET. The previous analyst recommendation was Overweight. ARCT was trading at $23.66 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
ARCT-810 Phase 2 study completed enrollment at 0.3 mg/kg dose level in Europe with data expected later this year ARCT-810 to expand Phase 2 clinical program in the U.S. to enroll patients with more severe disease ARCT-032 IND for Phase 2 multiple ascending dose study to be submitt...